Dow Up 0.48% Nasdaq Up 0.43%

Orexigen Therapeutics, Inc. (OREX)

-NasdaqGS
5.82 0.23(4.11%) Aug 19, 4:00PM EDT
Prev Close:5.59
Open:5.63
Bid:5.27 x 100
Ask:5.99 x 3000
1y Target Est:9.75
Beta:1.78
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:5.59 - 5.83
52wk Range:4.60 - 7.82
Volume:3,243,125
Avg Vol (3m):3,467,390
Market Cap:713.15M
P/E (ttm):N/A
EPS (ttm):-0.82
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
OREXUp 4.11%713.15M
ABT63.97B
GSK113.73B
RHHBY248.97B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):199.81
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.26
Quarterly EPS Est (Sep-14) :-0.05
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):0.07

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback